“SP was approaching 2.30 *after* the FDA letter dropped it to $2. Then the 13d reared their head and here we sit in the 1.80s
That’s a .50 drop due solely to the uncertainty of who the 13d are and what they claim to be planning.”
Entirely false.
The SP closed at $2.04 on May 17th, the day the FDA letter was released, a decrease of .78 or 27% from the opening SP of $2.82. The stock closed at $2 on the 18th and $1.81 on the 19th, 24 hours after the previous day’s CC.
The stock opened at $2.21 and closed at $2.12 on May 24th, the day the 13d 8k was released AFTER HOURS. The stock closed on the 25th at 2.01, a drop of .11 or 5% from $2.12. It closed at $1.99 the following day and $1.90 after that, only to rebound to a closing of $2.05, $2.06 and $2.11 in the 3 subsequent trading days.
So, please explain in detail how the 13d dropped the price .50 from $2.30 when the SP wasn’t near $2.30 when the 8k was released (it was $2.12) nor did the stock drop to $1.80 shortly after it was released (lowest was $1.90).
The stock fluctuations mostly entirely due to the FDA letter and the subsequent, abysmal CC.
Market Data 
Markets 
AI
